Table 1.
Characteristic | Healthy Controls | Patients with CD | p-value |
---|---|---|---|
No. of subjects (N) | 20 | 20 | |
No. of males (N) | 14 | 12 | 0.74 |
Mean age (SD) | 37.0 16.23) | 35.8 (15.81) | 0.84 |
Handedness (right/total) | (17/19) | (16/19) | 0.60 |
Mean years of education (SD) | 16.7 (1.9) | 16.02 (2.6) | 0.30 |
Median disease duration in years (SD) | N/A | 11.4 (9.0) | |
Disease location (N) | N/A | L1 5 L2 3 L3 11 L4 3 |
|
Disease behavior (N) | N/A | B1 11 B2 6 B3 0 P 2 |
|
IBD medications | N/A | Antibiotics 0 5-ASA 7 Immunomodulator 6 Anti-TNFα 9 Anti-Integrin 1 Corticosteroids 0 |
|
Average pain score (SD) (VAS, 0-10) |
N/A |
0.79 (0.84) |
|
Mean depression score (SD) | 10.15(6.23) | 11.21(6.48) | 0.61 |
5-ASA, 5 aminosalicylate; anti-TNFα, anti-tumor necrosis factor alpha agent; VAS, visual analog scale.